Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simran Singh

Showing results (91-100 of 91) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 91 results.
Journal for Immunotherapy of Cancer|July 11, 2022
TransCon IL-2 β/γ: a novel long-acting prodrug with sustained release of an IL-2Rβ/γ-selective IL-2 variant with improved pharmacokinetics and potent activation of cytotoxic immune cells for the treatment of cancerDavid B Rosen, Anne Månsson Kvarnhammar, Burkhardt Laufer, et al.
Pageof 10

Showing results (91-100 of 91) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 91 results.
Journal for Immunotherapy of Cancer|July 11, 2022
TransCon IL-2 β/γ: a novel long-acting prodrug with sustained release of an IL-2Rβ/γ-selective IL-2 variant with improved pharmacokinetics and potent activation of cytotoxic immune cells for the treatment of cancerDavid B Rosen, Anne Månsson Kvarnhammar, Burkhardt Laufer, et al.
Pageof 10